Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

• Status: Completed
• Trial end date: 2005-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril versus a comparator in the treatment of patients with complicated skin and skin structure infections.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Basilea Pharmaceutica
• Treatments: Ceftobiprole; Ceftobiprole medocaril; Cephalosporins; Vancomycin

Criteria

Inclusion Criteria:

• Diagnosis of an infection consistent with complicated skin and skin structure infections.

Exclusion Criteria:

• Known or suspected hypersensitivity to any study medication

• Any known or suspected condition or concurrent treatment contraindicated by the prescribing information

• Previous enrollment in this study

• Treatment with any investigational drug within 30 days before enrollment.